Dechra is pleased to announce the acquisition of Sucromate Equine (deslorelin acetate) sterile suspension from Thorn Bioscience L.L.C. This acquisition expands Dechra's equine portfolio in the reproductive category.
Mike Eldred, President of Dechra North America, stated, “Sucromate Equine is a sterile, synthetic gonadotropin-releasing hormone (GnRH) analog suspension that veterinarians have used and relied on for their breeding operations. Sucromate Equine expands Dechra's reproductive portfolio and complements our existing product offering.”
Sucromate Equine (deslorelin acetate) sterile suspension should be used exclusively by veterinarians.
The product is now available for veterinarians to purchase through select veterinary distributors.
Read more here.
The post Dechra Acquires Rights To Synthetic Reproductive Hormone Sucromate Equine appeared first on Horse Racing News | Paulick Report.
